California Stem Cell Pioneer Makes Passionate Plea at AAAS Forum
Robert Klein, who guided California's controversial stem cell measure to a historic win in November, said Thursday that therapies derived from the research could help taxpayers save billions of dollars in future medical costs for the treatment of debilitating diseases and injuries.
But at the 30th annual AAAS Forum on Science and Technology Policy, Klein warned that the new California Institute for Regenerative Medicine is already under attack in the courts and in Congress. And he urged medical and research scientists to join with doctors, patient rights groups and business interests nationwide in an alliance to defend and expand stem cell research.
For more information, read the full story.